Antibiotic resistance: turning evolutionary principles into clinical reality

被引:140
作者
Andersson, Dan, I [1 ]
Balaban, Nathalie Q. [2 ]
Baquero, Fernando [3 ]
Courvalin, Patrice [4 ]
Glaser, Philippe [5 ]
Gophna, Uri [6 ]
Kishony, Roy [7 ]
Molin, Soren [8 ]
Tonjum, Tone [9 ,10 ]
机构
[1] Uppsala Univ, Dept Med Biochem & Microbiol, BMC, Husargatan 3, S-75237 Uppsala, Sweden
[2] Hebrew Univ Jerusalem, Racah Inst Phys, Edmond J Safra Campus, IL-9190401 Jerusalem, Israel
[3] Ramon Y Cajal Hlth Res Inst, Dept Microbiol, Ctra Colmenar Viejo Km 9, Madrid 28034, Spain
[4] Inst Pasteur, French Natl Reference Ctr Antibiot, 25-28 Rue Dr Roux, F-75015 Paris, France
[5] Inst Pasteur, Ecol & Evolut Antibiot Resistance, 25-28 Rue Dr Roux, F-75015 Paris, France
[6] Tel Aviv Univ, Sch Mol Cell Biol & Biotechnol, 121 Jack Green Bldg, IL-6997801 Tel Aviv, Israel
[7] Technion, Fac Biol, IL-3200003 Haifa, Israel
[8] Tech Univ Denmark, Novo Nordisk Fdn Ctr Biosustainabil, Kemitorvet Bldg 220, DK-2800 Lyngby, Denmark
[9] Univ Oslo, Dept Microbiol, OUS HF Rikshosp, Postboks 4950, N-0424 Oslo, Norway
[10] Oslo Univ Hosp, POB 4950, N-0424 Oslo, Norway
关键词
antibiotic resistance; evolution; transmission; rapid diagnostics; prevention; new therapy; AMINOGLYCOSIDE-MODIFYING ENZYMES; ANTIMICROBIAL RESISTANCE; ESCHERICHIA-COLI; PSEUDOMONAS-AERUGINOSA; MYCOBACTERIUM-TUBERCULOSIS; PHAGE THERAPY; PARATYPHI B; BACTERIA; BETA; RESPONSES;
D O I
10.1093/femsre/fuaa001
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Antibiotic resistance is one of the major challenges facing modern medicine worldwide. The past few decades have witnessed rapid progress in our understanding of the multiple factors that affect the emergence and spread of antibiotic resistance at the population level and the level of the individual patient. However, the process of translating this progress into health policy and clinical practice has been slow. Here, we attempt to consolidate current knowledge about the evolution and ecology of antibiotic resistance into a roadmap for future research as well as clinical and environmental control of antibiotic resistance. At the population level, we examine emergence, transmission and dissemination of antibiotic resistance, and at the patient level, we examine adaptation involving bacterial physiology and host resilience. Finally, we describe new approaches and technologies for improving diagnosis and treatment and minimizing the spread of resistance.
引用
收藏
页码:171 / 188
页数:18
相关论文
共 193 条
[21]   Ample glycosylation in membrane and cell envelope proteins may explain the phenotypic diversity and virulence in the Mycobacterium tuberculosis complex [J].
Birhanu, Alemayehu Godana ;
Yimer, Solomon Abebe ;
Kalayou, Shewit ;
Riaz, Tahira ;
Zegeye, Ephrem Debebe ;
Holm-Hansen, Carol ;
Norheim, Gunnstein ;
Aseffa, Abraham ;
Abebe, Markos ;
Tonjum, Tone .
SCIENTIFIC REPORTS, 2019, 9 (1)
[22]   Nε- and O-Acetylation in Mycobacterium tuberculosis Lineage 7 and Lineage 4 Strains: Proteins Involved in Bioenergetics, Virulence, and Antimicrobial Resistance Are Acetylated [J].
Birhanu, Alemayehu Godana ;
Yimer, Solomon Abebe ;
Holm-Hansen, Carol ;
Norheim, Gunnstein ;
Aseffa, Abraham ;
Abebe, Markos ;
Tonjum, Tone .
JOURNAL OF PROTEOME RESEARCH, 2017, 16 (11) :4045-4059
[23]   Applying insights from biofilm biology to drug development - can a new approach be developed? [J].
Bjarnsholt, Thomas ;
Ciofu, Oana ;
Molin, Soren ;
Givskov, Michael ;
Hoiby, Niels .
NATURE REVIEWS DRUG DISCOVERY, 2013, 12 (10) :791-808
[24]   Effects of environment on compensatory mutations to ameliorate costs of antibiotic resistance [J].
Björkman, J ;
Nagaev, I ;
Berg, OG ;
Hughes, D ;
Andersson, DI .
SCIENCE, 2000, 287 (5457) :1479-1482
[25]  
Blanche A, 2019, CURR OPIN INFECT DIS, V32, P130, DOI [10.1097/QCO.0000000000000522, 10.1097/qco.0000000000000522]
[26]   The environmental side effects of medication - How are human and veterinary medicines in soils and water bodies affecting human and environmental health? [J].
Boxall, ABA .
EMBO REPORTS, 2004, 5 (12) :1110-1116
[27]   Distinguishing between resistance, tolerance and persistence to antibiotic treatment [J].
Brauner, Asher ;
Fridman, Ofer ;
Gefen, Orit ;
Balaban, Nathalie Q. .
NATURE REVIEWS MICROBIOLOGY, 2016, 14 (05) :320-330
[28]  
Brockman KL, 2018, MBIO, V9, DOI [10.1128/mBio.01682-18, 10.1128/mbio.01682-18]
[29]   Antibiotic resistance breakers: can repurposed drugs fill the antibiotic discovery void? [J].
Brown, David .
NATURE REVIEWS DRUG DISCOVERY, 2015, 14 (12) :821-832
[30]   Increased Susceptibility of Pseudomonas aeruginosa to Macrolides and Ketolides in Eukaryotic Cell Culture Media and Biological Fluids Due to Decreased Expression of oprM and Increased Outer-Membrane Permeability [J].
Buyck, Julien M. ;
Plesiat, Patrick ;
Traore, H. ;
Vanderbist, F. ;
Tulkens, Paul M. ;
Van Bambeke, Francoise .
CLINICAL INFECTIOUS DISEASES, 2012, 55 (04) :534-542